Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Food Chem Toxicol ; 38 Suppl 2: S123-9, 2000.
Artigo em Inglês | MEDLINE | ID: mdl-10882825

RESUMO

Two tolerance studies were conducted in healthy human adult volunteers. The first study was an ascending dose study conducted in eight subjects, in which sucralose was administered at doses of 1, 2. 5, 5 and 10mg/kg at 48-hour intervals and followed by daily dosing at 2mg/kg for 3 days and 5mg/kg for 4 days. In the second study, subjects consumed either sucralose (n=77) or fructose (50g/day) (n=31) twice daily in single blind fashion. Sucralose dosage levels were 125mg/day for weeks 1-3, 250mg/day during weeks 4-7, and 500mg/day during weeks 8-12. No adverse experiences or clinically detectable effects were attributable to sucralose in either study. Similarly, haematology, serum biochemistry, urinalysis and EKG tracings were unaffected by sucralose administration. In the 13-week study, serial slit lamp ophthalmologic examination performed in a random subset of the study groups revealed no changes. Fasting and 2-hour post-dosing blood sucralose concentrations obtained daily during week 12 of the study revealed no rising trend for blood sucralose. Sucralose was well tolerated by human volunteers in single doses up to 10mg/kg/day and repeated doses increasing to 5mg/kg/day for 13 weeks. Based on these studies and the extensive animal safety database, there is no indication that adverse effects on human health would occur from frequent or long-term exposure to sucralose at the maximum anticipated levels of intake.


Assuntos
Sacarose/análogos & derivados , Edulcorantes/farmacologia , Administração Oral , Adolescente , Adulto , Análise Química do Sangue , Cromatografia Líquida de Alta Pressão , Feminino , Cromatografia Gasosa-Espectrometria de Massas , Testes Hematológicos , Humanos , Insulina/sangue , Masculino , Pessoa de Meia-Idade , Oftalmoscopia , Método Simples-Cego , Sacarose/administração & dosagem , Sacarose/sangue , Sacarose/farmacologia , Sacarose/urina , Edulcorantes/administração & dosagem , Urinálise
3.
Br J Ind Med ; 33(4): 217-29, 1976 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-793610

RESUMO

Data are presented on the effects on health of talc dusts from exposure in industry and use of talc-containing health products. The mineralogy of talc and the composition of cosmetic and industrial grade talc dusts are described. Studies in animals are reviewed, and epidemiological data are considered in relation to exposures that occur during industrial and consumer uses of talc dusts. Hamsters exposed to 8 mg/m3 of respirable cosmetic grade talc dust for up to 150 minutes a day for 300 consecutive days showed no difference in incidence or nature of pathological lesions from those observed in a group of untreated animals. A retrospective study of the causes of death of 227 talc mine millers exposed to cosmetic grade talc at the threshold limit value for talc (20 million parts per cubic foot) for an average of 15-8 years showed that the causes of death were no different from those in a control cohort not exposed to talc dust. The available data indicate that talc dust exposure in the modern mining of cosmetic grade talc does not appear to be injurious to health. The significantly lower dust exposure in the normal use of cosmetic grade talc dusts in talc-containing health and cosmetic products confirms that their use is not a hazard to health.


Assuntos
Talco , Animais , Fenômenos Químicos , Química , Pré-Escolar , Cosméticos , Cricetinae , Relação Dose-Resposta a Droga , Poeira , Exposição Ambiental , Humanos , Lactente , Pulmão/efeitos dos fármacos , Mineração , Mutagênicos , Neoplasias/etiologia , Medicina do Trabalho , Pneumoconiose/etiologia , Ratos , Talco/farmacologia , Talco/toxicidade
7.
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA